Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIM-PTL: Prediction Models in Preterm Labor
NCT04831086Phase 3Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- May 2021
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Total antenatal steroid doses. Started May 2021; status: completed.
Beyond the preview
Go deeper on NCT04831086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04831086.